Pharmadrug Inc. LMLLF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

7/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Pharmadrug Inc. (LMLLF) reported total assets of $557.24K and total liabilities of $2.07M for quarter ending 2025-09-30, resulting in total equity of $-1.51M.

The company held $6.49K in cash and short-term investments. Total debt stood at $1.49M, with net debt of $1.48M. The Debt-to-Equity (D/E) ratio was -0.99 (conservative).

Current ratio is 0.01, which may signal tight short-term liquidity. Interest coverage is -0.5x (weak).

Criteria supported by this page:

HEALTH (0/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (11/100) — Total assets $557.24K and equity $-1.51M support the company's competitive scale

Overall SharesGrow Score: 6/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

7/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

✗

HEALTH

0/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

11/100

Proven by this page

✗

GROWTH

15/100

→ Income

—

INCOME

N/A

No coverage

Pharmadrug Inc. Balance Sheet History

Metric	Q3 FY2025	Q2 FY2025	Q1 FY2025	Q4 FY2024
Total Assets	$557.24K	$578.37K	$662.17K	$711.8K
Total Liabilities	$2.07M	$2M	$2M	$1.96M
Total Debt	$1.49M	$1.43M	$1.38M	$1.35M
Cash & Investments	$6.49K	$17.72K	$74.77K	$75.04K
Total Stockholders Equity	$-1.63M	$-1.55M	$-1.48M	$-1.4M